Bachem Holding AG
BANB
Rang in Aktien
#2516
Bachem Holding AG serves pharmaceutical and biotechnology companies globally,... Bachem Holding AG serves pharmaceutical and biotechnology companies globally, providing products crucial for research, clinical development, and commercial use. The company's primary focus is on the design, manufacturing, and regulatory support for peptide active pharmaceutical ingredients (APIs), specifically targeting novel peptide and oligonucleotide chemical entities (NCEs). Additionally, Bachem offers commercially available NCEs and generic compounds. Its comprehensive service portfolio includes project management, quality assurance and regulatory guidance, analytical testing, production adhering to Good Manufacturing Practices (GMP), manufacturing for research purposes, and expertise in supply chain and vertical integration. Established in 1971, Bachem Holding AG is headquartered in Bubendorf, Switzerland, and functions as a subsidiary of Ingro Finanz AG.
Aktienkurs
$100.60
Marktkapitalisierung
$7.54B
Veränderung (1 Tag)
-1.49%
Veränderung (1 Jahr)
49.53%
Land
CH
Handel Bachem Holding AG (BANB)
Kategorie
Healthcare
P/B-Verhältnis für Bachem Holding AG (BANB)
P/B-Verhältnis zum October 2026 TTM: 4.31
Laut den neuesten Finanzberichten und dem Aktienkurs von Bachem Holding AG beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) 4.31. Am Ende des Jahres 2024 lag das P/B-Verhältnis bei 3.12.
P/B-Verlauf für Bachem Holding AG von 2002 bis 2026
P/B-Verhältnis zum Jahresende
| Jahr | P/B-Verhältnis | ändert |
|---|---|---|
| 2026 (TTM) | 4.31 | 40.03% |
| 2025 | 3.08 | -1.34% |
| 2024 | 3.12 | -15.11% |
| 2023 | 3.68 | -26.96% |
| 2022 | 5.03 | -44.38% |
| 2021 | 9.05 | -22.23% |
| 2020 | 11.64 | 143.30% |
| 2019 | 4.78 | 18.05% |
| 2018 | 4.05 | -27.47% |
| 2017 | 5.59 | 66.84% |
| 2016 | 3.35 | 68.44% |
| 2015 | 1.99 | 4.79% |
| 2014 | 1.90 | -2.54% |
| 2013 | 1.95 | 29.71% |
| 2012 | 1.50 | 14.42% |
| 2011 | 1.31 | -37.56% |
| 2010 | 2.10 | -11.45% |
| 2009 | 2.37 | -17.55% |
| 2008 | 2.88 | -18.65% |
| 2007 | 3.54 | 13.43% |
| 2006 | 3.12 | -76.81% |
| 2005 | 13.44 | 424.43% |
| 2004 | 2.56 | 2,367.37% |
| 2003 | 0.10 | 11,444.44% |
| 2002 | 0.00 | 0.00% |
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | P/B-Verhältnis | P/B-Verhältnis-Differenz | Land |
|---|---|---|---|
| 6.251 | 44.93% |
US
|
|
| 13.2547 | 207.32% |
US
|
|
| 4.4521 | 3.23% |
AU
|
|
| 6.3632 | 47.54% |
NL
|
|
| - | - |
CH
|
